What caused the ABVX.PA stock drop after hours?

The after hours drop to **EUR 97.40** on 24 Mar 2026 reflects heavier selling, clinical-programme newsflow and sector rotation in European biotech. Volume rose to **182,513**, signalling outsized selling versus the average **193,172**.

What is Meyka AI's grade for ABVX.PA stock and what does it mean?

Meyka AI rates ABVX.PA with a score out of 100: **74.33 | Grade B+ | Suggestion: BUY**. The grade factors benchmarks, sector, financial growth, metrics and analyst consensus. Grades are informational and not financial advice.

What price targets and forecast does Meyka AI give for ABVX.PA?

Meyka AI's forecast model projects monthly **EUR 100.11** and yearly **EUR 51.19**. The monthly figure implies about **2.72%** upside and the yearly implies about **-47.43%** downside from **EUR 97.40**. Forecasts are projections, not guarantees.

Should I trade ABVX.PA after hours on EURONEXT?

After hours trading can widen spreads and increase volatility. Monitor order book depth, set strict size limits and use stops. Consider event risk from ABIVAX’s clinical timetable before taking directional positions.

EU Stocks

ABVX.PA ABIVAX SA (EURONEXT) -10.97% after hours 24 Mar 2026: catalysts ahead

ByDanny Kontos March 24, 2026

ABVX.PA stock plunged -10.97% in after hours trade on 24 Mar 2026, dropping to EUR 97.40 on EURONEXT in Europe after a EUR 12.00 intraday move. The decline followed a session in which volume reached 182,513 shares versus an average of 193,172, signalling heavier selling. Investors are parsing company updates and trial timelines for ABIVAX SA as biotech peers and sector flows weigh on the stock. We break down the drivers, technicals, the Meyka AI grade and model forecasts to show what matters next for traders and longer-term holders.